# 바이오스페이스 일일 뉴스 리포트 - 2025년 11월 11일


## 주요 헤드라인

1. **Kezar Loses 70% of Staff After FDA Cancels Meeting on Autoimmune Asset (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/kezar-loses-70-of-staff-after-fda-cancels-meeting-on-autoimmune-asset>

2. **Kezar Loses 70% of Staff After FDA Cancels Meeting on Autoimmune Asset (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/kezar-loses-70-of-staff-after-fda-cancels-meeting-on-autoimmune-asset>

3. **Despite Obesity Drug Pricing Deal, GLP-1 Compounders Continue To Operate in the Shadows (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/despite-obesity-drug-pricing-deal-glp-1-compounders-continue-to-operate-in-the-shadows>

4. **Lilly Doubles Down on Eye Diseases, Adding to BD Spree (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/lilly-doubles-down-on-eye-diseases-adding-to-bd-spree>

5. **Ionis’ Tryngolza ‘Game-Changing in Lowering Triglycerides, Cementing Case for FDA Filing (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/ionis-tryngolza-game-changing-in-lowering-triglycerides-cementing-case-for-fda-filing>

6. **Amgen’s Repatha Cuts Risk of First Heart Attack by 36% in Phase III Trial (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/amgens-repatha-cuts-risk-of-first-heart-attack-by-36-in-phase-iii-trial>

7. **From Weight Loss to Hair Loss (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/from-weight-loss-to-hair-loss-the-search-for-the-next-blockbuster>


---
*2025년 11월 11일 바이오스페이스 뉴스 피드에서 생성된 리포트*